What is Quanterix Corporation's market cap?

Quanterix Corporation (QTRX) has a market capitalization of $172.9M and trades on NASDAQ.

What is Quanterix Corporation's revenue and profitability?

Quanterix Corporation generated $145.0M in trailing twelve-month revenue with a net loss of $104.2M, representing a net margin of -71.9%. Gross margin stands at 44.2%, with free cash flow of -$82.9M. These figures are based on the Q1 2026 filing.

Who are Quanterix Corporation's competitors?

Quanterix Corporation's key competitors include Bio-Rad Laboratories, Thermo Fisher Scientific, Revvity, Inc., and others. These companies compete in similar markets and product categories.

Where is Quanterix Corporation headquartered?

Quanterix Corporation is headquartered in United States of America and employs approximately 141 people. It has been publicly traded since 2017.

Quanterix Corporation

QTRX

Quanterix is a life sciences company specializing in ultra-sensitive digital immunoassay and spatial biology platforms.

Market cap

$172.88M-39.2%

Revenue$145.0M+6.9%

Net income-$104.2M-118%

Free cash flow-$82.9M-151%

EPS (diluted)-$2.34-88.7%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$36.4MMiss by $426.3K EPS-$0.39Miss by $0.08

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$37.5M

EPS estimate-$0.41

Financials

Q1 2026

Income statement

See full

Revenue$36.4M+20.1%

Gross profit$15.6M+4.9%

Operating income-$41.4M-56.9%

Net income-$17.5M+14.5%

EPS (diluted)-$0.37+30.2%

Balance sheet

See full

Cash & equivalents$36.2M-52.7%

Total debt$35.3M-2.9%

Total equity$282.1M-10.8%

Total assets$366.7M-7.5%

Cash flow

See full

Operating cash flow-$18.1M-30.4%

CapEx$87.0K-93.1%

Free cash flow-$18.2M-20.1%

Valuation & ratios

Valuation

See full

Market cap$172.88M-39.2%

Enterprise value$172.03M-16.3%

P/S1.2×-1.2×

Profitability

See full

Gross margin44.2%-14.3pp

Operating margin-96.9%-1,691pp

Net margin-71.9%-2,019pp

FCF margin-57.2%-220pp

Returns & leverage

See full

Return on equity-34.8%-122pp

Debt / equity0.1×0.0×

Current ratio3.7×-4.6×

Segments

By product

See full

Consumable and other products$21.4M+18.0%

Simoa$6.7M—

Research services$4.4M-22.3%

Instruments$4.1M+56.2%

Spatial Biology$3.7M—

Competitors

By market cap

Thermo Fisher Scientific$207.93B+13.6%

Agilent Technologies$38.9B+14.7%

Revvity$12.1B+7.6%

Bio-Rad Laboratories$8.5B+22.9%

QuidelOrtho Corporation$1.1B-35.0%

Pacific Biosciences of California$422.4M-14.2%

Biodesix, Inc.$230.1M+277%

Quanterix Corporation$172.9M-42.9%

By revenue growth

Biodesix, Inc.+29.0%

Agilent Technologies+9.1%

Quanterix Corporation+6.9%

Thermo Fisher Scientific+5.6%

Pacific Biosciences of California+5.0%

Revvity+4.8%

Bio-Rad Laboratories+1.9%

QuidelOrtho Corporation-3.9%

By net margin

Agilent Technologies19.55%+2.0pp

Thermo Fisher Scientific15.19%0.0pp

Revvity8.26%-2.1pp

Bio-Rad Laboratories6.52%+91.7pp

Biodesix, Inc.-33.26%+21.0pp

QuidelOrtho Corporation-45.57%-32.6pp

Quanterix Corporation-71.86%-36.6pp

Pacific Biosciences of California-80.34%+353pp

Profile

Quanterix is a life sciences company specializing in ultra-sensitive digital immunoassay and spatial biology platforms. The company enables the detection of protein biomarkers at extremely low concentrations to facilitate early disease detection, monitoring, and the development of novel therapies across neurology, oncology, and immunology.

Competitive position

A leader in ultra-sensitive protein detection with a significant installed base and extensive scientific validation through peer-reviewed publications.

GeographiesNorth America, Europe, Asia-Pacific

Customer segmentsBiopharmaceutical companies, Academic research institutions, Contract Research Organizations (CROs)

Business modelRazor-and-blade, Equipment sales, Service-based, Direct sales

SuppliersSpecialized chemical suppliers, Precision electronic component manufacturers, Raw material providers for consumables

CustomersDrug development teams, Clinical diagnostic labs, Academic researchers, Medical practitioners

CountryUnited States of America

Listed2017

Employees141.0

CEOEverett V. Cunningham

SectorHealthcare

IndustryMedical - Devices

Websitequanterix.com

FilingsSEC EDGAR

Ask your AI about Quanterix Corporation.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Quanterix Corporation's market cap?: Quanterix Corporation (QTRX) has a market capitalization of $172.9M and trades on NASDAQ.
What is Quanterix Corporation's revenue and profitability?: Quanterix Corporation generated $145.0M in trailing twelve-month revenue with a net loss of $104.2M, representing a net margin of -71.9%. Gross margin stands at 44.2%, with free cash flow of -$82.9M. These figures are based on the Q1 2026 filing.
Who are Quanterix Corporation's competitors?: Quanterix Corporation's key competitors include Bio-Rad Laboratories, Thermo Fisher Scientific, Revvity, Inc., and others. These companies compete in similar markets and product categories.
Where is Quanterix Corporation headquartered?: Quanterix Corporation is headquartered in United States of America and employs approximately 141 people. It has been publicly traded since 2017.